CCP
PFE icon

Clarkston Capital Partners’s Pfizer PFE Stock Holding History

Clarkston Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-84,036
Closed -$2.09M – 156
2025
Q4 		$2.09M Buy
84,036
+2,320
+3% +$58.5K 0.05% 102
2025
Q3 		$2.08M Buy
81,716
+28
+0% +$691 0.04% 92
2025
Q2 		$1.98M Buy
81,688
+15,000
+22% +$350K 0.04% 90
2025
Q1 		$1.69M Buy
66,688
+10,000
+18% +$262K 0.03% 87
2024
Q4 		$1.5M Sell
56,688
-1,089
-2% -$29.5K 0.03% 90
2024
Q3 		$1.67M Buy
57,777
+13,700
+31% +$400K 0.03% 86
2024
Q2 		$1.23M Sell
44,077
-5,782
-12% -$159K 0.02% 95
2024
Q1 		$1.38M Hold
49,859
– – 0.02% 92
2023
Q4 		$1.44M Sell
49,859
-26,100
-34% -$789K 0.03% 82
2023
Q3 		$2.52M Sell
75,959
-600
-0.8% -$21.2K 0.05% 65
2023
Q2 		$2.81M Sell
76,559
-930
-1% -$36.2K 0.05% 61
2023
Q1 		$3.16M Sell
77,489
-2,187
-3% -$94.5K 0.06% 58
2022
Q4 		$4.08M Buy
79,676
+428
+0.5% +$20.5K 0.08% 54
2022
Q3 		$3.47M Buy
79,248
+1,100
+1% +$53.5K 0.07% 53
2022
Q2 		$4.1M Sell
78,148
-51
-0.1% -$2.6K 0.08% 52
2022
Q1 		$4.05M Sell
78,199
-88
-0.1% -$4.57K 0.07% 52
2021
Q4 		$4.62M Buy
78,287
+40,139
+105% +$1.99M 0.08% 49
2021
Q3 		$1.64M Buy
38,148
+129
+0.3% +$5.71K 0.03% 64
2021
Q2 		$1.49M Sell
38,019
-4,875
-11% -$190K 0.03% 71
2021
Q1 		$1.55M Buy
+42,894
New +$1.52M 0.03% 64
2019
Q3 		– Sell
-6,487
Closed -$267K – 114
2019
Q2 		$267K Sell
6,487
-1,425
-18% -$56.6K 0.01% 90
2019
Q1 		$319K Sell
7,912
-305,173
-97% -$12.2M 0.01% 85
2018
Q4 		$13M Sell
313,085
-3,542
-1% -$147K 0.5% 44
2018
Q3 		$13.2M Buy
316,627
+701
+0.2% +$27K 0.48% 44
2018
Q2 		$10.9M Sell
315,926
-2,393
-0.8% -$81.8K 0.42% 42
2018
Q1 		$10.7M Buy
318,319
+6,588
+2% +$226K 0.42% 43
2017
Q4 		$10.7M Buy
311,731
+7,778
+3% +$265K 0.42% 42
2017
Q3 		$10.3M Buy
303,953
+5,855
+2% +$188K 0.42% 43
2017
Q2 		$9.5M Buy
298,098
+20,791
+7% +$656K 0.42% 45
2017
Q1 		$9M Buy
277,307
+77,789
+39% +$2.45M 0.42% 46
2016
Q4 		$6.15M Sell
199,518
-226,297
-53% -$6.91M 0.29% 49
2016
Q3 		$13.7M Buy
425,815
+2,483
+0.6% +$83K 0.66% 44
2016
Q2 		$14.1M Buy
423,332
+15,169
+4% +$484K 0.74% 44
2016
Q1 		$11.5M Buy
408,163
+9,254
+2% +$264K 0.64% 45
2015
Q4 		$12.2M Sell
398,909
-17,813
-4% -$560K 0.85% 41
2015
Q3 		$12.4M Buy
416,722
+3,489
+0.8% +$112K 1.13% 39
2015
Q2 		$13.1M Buy
413,233
+7,729
+2% +$252K 1.35% 31
2015
Q1 		$13.4M Buy
405,504
+179,661
+80% +$5.71M 1.48% 28
2014
Q4 		$6.67M Buy
225,843
+10,403
+5% +$298K 1.01% 33
2014
Q3 		$6.04M Buy
215,440
+14,579
+7% +$409K 1.04% 32
2014
Q2 		$5.66M Buy
200,861
+9,661
+5% +$275K 1.04% 31
2014
Q1 		$5.83M Buy
191,200
+26,408
+16% +$787K 1.16% 31
2013
Q4 		$4.79M Buy
164,792
+9,812
+6% +$286K 1.87% 16
2013
Q3 		$4.22M Buy
154,980
+9,065
+6% +$247K 2.04% 15
2013
Q2 		$3.88M Buy
+145,915
New +$4.03M 2.15% 15

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Clarkston Capital Partners's PFE Position: Q1 2026 in Review

Clarkston Capital Partners sold out of Pfizer (PFE) in Q1 2026, closing a stake of 84,036 shares — an estimated $2.09M sold.

Clarkston Capital Partners first reported a position in PFE in Q2 2013 and held it in 45 quarters. The position peaked at $14.1M in Q2 2016. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Clarkston Capital Partners reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Clarkston Capital Partners sold 84,036 Pfizer shares in Q1 2026, an estimated $2.09M.
  • Clarkston Capital Partners first reported a position in Pfizer in Q2 2013 and held it in 45 quarters.
  • Clarkston Capital Partners's Pfizer position peaked at $14.1M in Q2 2016.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Clarkston Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.